Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Combination Product: mavrilimumab1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 41
2MAVRILIMUMAB1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 41, 46
3Mavrilimumab 10 mg1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
4Mavrilimumab 100 mg1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
5Mavrilimumab 150 mg1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
6Mavrilimumab 30 mg1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
7Mavrilimumab 50 mg1件: Mavrilimumab1件: D09930 (Name: Mavrilimumab)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46